ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, has announced that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR.
The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both hospital and EMS settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use.
Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customisation, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations.
Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare providers real-time clinical feedback to improve ventilation quality and deliver high-quality CPR.1 The advanced technology of Zenix empowers hospital clinicians and EMS teams to make informed, confident decisions and ensure they are delivering exceptional patient care, every time.
“Whether you are a hospital clinician or an EMS professional, the ZOLL Zenix monitor/defibrillator is designed to work the way you work,” said Elijah White, President of ZOLL Acute Care Technology. “Zenix is our most advanced monitor/defibrillator, and yet it’s incredibly easy to use - virtually all functions of the device are accessible with three screen-touches or less. Along with the X Series®, R Series® and ZOLL M2®, Zenix extends ZOLL’s leadership in professional monitors/defibrillators with unique features and intuitive design.”
For more information, visit https://www.zoll.com/en-gb/products/emergency-care/monitors-and-defibrillators
Reference
1 ‘The Heart of the Matter: What really defibrillates the heart?’ ZOLL White Paper, 2015.